Nitrosamines
Why in the News?
- In August 2026, Nitrosamines returned to intense global regulatory and public health focus after prominent toxicological evaluations warned of the widespread presence of these "hidden carcinogens" across everyday food, drinking water sources, and essential pharmaceuticals.
- Concurrently, global health bodies like the USFDA and Australia’s Therapeutic Goods Administration (TGA) have enforced rigorous, updated Acceptable Intake (AI) limits and compliance timelines for global drug manufacturers to eliminate these genotoxic impurities.
- Nitrosamines (formally N-nitrosamines) are a class of organic chemical compounds characterized by the R₂N-N=O functional group, where a nitroso group (NO⁺) is directly bonded to a deprotonated amine.
- They are classified as "probable human carcinogens" and are designated as a Cohort of Concern under the International Council for Harmonisation (ICH) M7 guidelines due to their exceptional mutagenic potency.
Nitrosamines are not intentionally added but are formed as secondary byproducts when amines (secondary or tertiary) chemically react with nitrites or nitrates under specific conditions, including:
- Acidic environments (such as gastric juices in the human stomach).
- High thermal exposure (such as frying or grilling food).
- The presence of oxidising agents or contaminated solvents.
- Dietary Sources: Found in cured, fried, or processed meats (due to sodium nitrite preservatives), processed fish, beer, and fermented foods.
- Drinking Water: N-nitrosodimethylamine (NDMA) is a highly potent nitrosamine that forms during water chlorination/chloramine disinfection when chlorine reacts with local organic nitrogen compounds.
- Pharmaceuticals (NDSRIs): Nitrosamine Drug Substance-Related Impurities (NDSRIs) form during manufacturing scale-up, or when active pharmaceutical ingredients (APIs) interact with residual nitrites in excipients or packaging material under heat and moisture.
- Tobacco: Tobacco-specific nitrosamines (TSNAs) are major components in cigarette smoke.
- DNA Adduct Formation: Inside the human body, nitrosamines are metabolically activated by Cytochrome P450 enzymes. This activation leads to the formation of reactive ions that damage DNA by binding to it (forming DNA adducts), triggering mutations that progress into stomach, colorectal, liver, or pancreatic cancers.
- No "Safe" Threshold: Unlike typical chemical impurities, genotoxic impurities can cause damage even at nanogram (ng) levels over long periods of cumulative exposure.
- Strict Daily Thresholds: The USFDA has restricted compound-specific intake limits to a narrow range of 26.5 to 96 ng/day, enforcing a default threshold of just 18 ng/day for any uncharacterized nitroso-compounds.
- Pharma Compliance Shifts: Global health regulators have transitioned from a simple "testing-only" approach to demanding root-cause elimination. Manufacturers must now reformulate drugs using specific antioxidants (like ferulic acid or caffeic acid) or pH modifiers to chemically inhibit nitrosamine formation during storage.
- Pharma Capital Vulnerability: As the "Pharmacy of the World," Indian generic drug exporters face immense scrutiny. Inadequate testing infra or contaminated raw solvents can cause export rejections and damage international credibility.
- Aquatic Eco-Toxicology: Effluents from wastewater treatment plants containing nitrosating agents often bypass strict processing, causing bioaccumulation in aquatic life and finding their way into the human food chain via domestic fish supplies.
